Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a combination product containing omeprazole, amoxicillin, and clarithromycin, indicated for the eradication of *Helicobacter pylori* (*H. pylori*) infection.
## Primary Indications
Eradication of *H. pylori* infection in patients with duodenal or gastric ulcers.
## Adult Dosing
**Sompraz HP** contains:
* Omeprazole 20 mg
* Amoxicillin 1000 mg (given as two 500 mg capsules)
* Clarithromycin 500 mg
This combination is typically administered twice daily for 10 to 14 days. The exact regimen may vary based on local resistance patterns and clinical guidelines.
## Pediatric Dosing
Sompraz HP is **not approved** for use in pediatric patients. Dosing for *H. pylori* eradication in children is not established with this specific combination product and should be guided by specialized pediatric infectious disease or gastroenterology protocols, often utilizing weight-based dosing of individual components.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment for the components of Sompraz HP, though caution and monitoring are advised in severe hepatic dysfunction. However, if *H. pylori* eradication fails, subsequent treatment regimens may differ and require dose adjustments based on individual components and patient factors.
## Contraindications
* Hypersensitivity to omeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of penicillin-induced jaundice or hepatic dysfunction.
* Concomitant use with cisapride, pimozide, quinidine, or astemizole due to risk of QT prolongation and arrhythmias (contraindicated with clarithromycin).
* Severe renal impairment may require dose adjustment of amoxicillin if administered separately.
## Adverse Effects
Common adverse effects include:
* **Gastrointestinal:** Diarrhea, nausea, vomiting, abdominal pain, taste perversion.
* **Allergic Reactions:** Rash, urticaria, anaphylaxis.
* **Other:** Headache, dizziness, fungal infections.
* **Serious:** *Clostridium difficile*-associated diarrhea, hepatic dysfunction, Stevens-Johnson syndrome, toxic epidermal necrolysis.
## Key Drug Interactions
* **Omeprazole:** May decrease the absorption of drugs requiring gastric acidity (e.g., ketoconazole, itraconazole, digoxin). May increase serum concentrations of certain drugs metabolized by CYP2C19 (e.g., clopidogrel, voriconazole).
* **Clarithromycin:** Potent inhibitor of CYP3A4. May increase serum concentrations of numerous drugs including statins (e.g., simvastatin, lovastatin), warfarin, theophylline, certain benzodiazepines, calcium channel blockers, and colchicine. Contraindicated with cisapride, pimozide, astemizole, and quinidine.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid may increase and prolong serum levels of amoxicillin.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Monitor for diarrhea, particularly *C. difficile*-associated diarrhea.
* Assess for efficacy of *H. pylori* eradication via urea breath test, stool antigen test, or endoscopy (typically 4-6 weeks post-treatment).
* Evaluate hepatic function periodically, especially with prolonged use or in patients with pre-existing liver disease.
## Clinical Pearls
* Administer the entire contents of the Sompraz HP pack twice daily for 10 to 14 days.
* Omeprazole should be taken before a meal.
* It is crucial to complete the entire course of therapy to ensure eradication of *H. pylori*.
* Patients should be advised to report any severe diarrhea or signs of a severe allergic reaction immediately.
* Consider local *H. pylori* resistance patterns when selecting or confirming the appropriateness of this regimen.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions. Drug formulations and availability may vary by region.
